Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 4/2018

01-04-2018 | Correction

Correction to: Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren’s syndrome: a case report and review of the literature

Authors: Yan Geng, Youlu Zhao, Zhuoli Zhang

Published in: Clinical Rheumatology | Issue 4/2018

Login to get access

Excerpt

Correction to: Clin Rheumatol …
Metadata
Title
Correction to: Tubulointerstitial nephritis-induced hypophosphatemic osteomalacia in Sjögren’s syndrome: a case report and review of the literature
Authors
Yan Geng
Youlu Zhao
Zhuoli Zhang
Publication date
01-04-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 4/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-3994-5

Other articles of this Issue 4/2018

Clinical Rheumatology 4/2018 Go to the issue

Original Article

Splenectomy in systemic lupus erythematosus and autoimmune hematologic disease: a comparative analysis

Original Article

The value of high-sensitivity C-reactive protein in hand and knee radiographic osteoarthritis: data from the Dong-gu Study

Case Based Review

Anti-fibrotic nintedanib—a new opportunity for systemic sclerosis patients?

Original Article

Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus

Original Article

Vasodilator function worsens after cessation of tumour necrosis factor inhibitor therapy in patients with rheumatoid arthritis only if a flare occurs

Original Article

Prevalence and type II diabetes-associated factors in psoriatic arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits